Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-048535
Filing Date
2021-09-17
Accepted
2021-09-17 14:48:53
Documents
1
Period of Report
2021-09-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4070
  Complete submission text file 0001213900-21-048535.txt   5538
Mailing Address C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170
Business Address
Pecora Andrew L (Reporting) CIK: 0001510184 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 211260063

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations